Hiromu Horitani

Short-term efficacy and safety of enfortumab vedotin plus pembrolizumab as a first-line treatment for advanced urothelial carcinoma regardless of cisplatin eligibility.

Journal: Japanese journal of clinical oncology

Published: May 27, 2026

Prognostic significance of the FAN score in patients with advanced urothelial carcinoma treated with enfortumab vedotin monotherapy.

Journal: Japanese journal of clinical oncology

Published: May 11, 2026

Peripheral B-cell receptor repertoire predicts immune-related adverse events following immune checkpoint inhibitor therapy in advanced renal cell carcinoma.

Journal: Scientific reports

Published: April 02, 2026

Microbiome-Driven Carcinogenesis and Circulating Microbial Signals in Genitourinary Cancers.

Journal: Cancer science

Published: April 01, 2026

Neutrophil-to-lymphocyte ratio and performance status are associated with increased risk of skin toxicity in patients receiving enfortumab vedotin with or without pembrolizumab for metastatic urothelial carcinoma.

Journal: Cancer treatment and research communications

Published: March 26, 2026

Perioperative safety and oncological outcomes of robot-assisted radical cystectomy in patients aged ≥80 years: A propensity score-matched multi-institutional study.

Journal: Surgical oncology

Published: January 29, 2026

Preoperative FAN score predicts survival outcomes after radical cystectomy for bladder cancer.

Journal: BJUI compass

Published: January 06, 2026

Myosteatosis Predicts Poor Prognosis in Patients With Castration-Resistant Prostate Cancer Treated With Enzalutamide.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: November 20, 2025

Bone scan index rise prior to osteonecrosis of the jaw with bone-modifying agents in prostate cancer.

Journal: BJUI compass

Published: October 16, 2025

The First Case of Bacillus Calmette-Guérin-Induced Autoimmune Encephalitis.

Journal: IJU case reports

Published: September 11, 2025

Real-world efficacy and safety of pembrolizumab plus lenvatinib in patients with metastatic renal cell carcinoma: a multi-institutional retrospective study.

Journal: Scientific reports

Published: July 06, 2025

Pyonephrosis Caused by Ureteral Stricture Due to Syphilitic Granuloma: A Case Report

Journal: Hinyokika kiyo. Acta urologica Japonica

Published: June 05, 2025

Short-term efficacy and safety of enfortumab vedotin plus pembrolizumab as a first-line treatment for advanced urothelial carcinoma regardless of cisplatin eligibility.

Short-term efficacy and safety of enfortumab vedotin plus pembrolizumab as a first-line treatment for advanced urothelial carcinoma regardless of cisplatin eligibility.

Prognostic significance of the FAN score in patients with advanced urothelial carcinoma treated with enfortumab vedotin monotherapy.

Prognostic significance of the FAN score in patients with advanced urothelial carcinoma treated with enfortumab vedotin monotherapy.

Peripheral B-cell receptor repertoire predicts immune-related adverse events following immune checkpoint inhibitor therapy in advanced renal cell carcinoma.

Peripheral B-cell receptor repertoire predicts immune-related adverse events following immune checkpoint inhibitor therapy in advanced renal cell carcinoma.

Microbiome-Driven Carcinogenesis and Circulating Microbial Signals in Genitourinary Cancers.

Microbiome-Driven Carcinogenesis and Circulating Microbial Signals in Genitourinary Cancers.

Neutrophil-to-lymphocyte ratio and performance status are associated with increased risk of skin toxicity in patients receiving enfortumab vedotin with or without pembrolizumab for metastatic urothelial carcinoma.

Neutrophil-to-lymphocyte ratio and performance status are associated with increased risk of skin toxicity in patients receiving enfortumab vedotin with or without pembrolizumab for metastatic urothelial carcinoma.

Perioperative safety and oncological outcomes of robot-assisted radical cystectomy in patients aged ≥80 years: A propensity score-matched multi-institutional study.

Perioperative safety and oncological outcomes of robot-assisted radical cystectomy in patients aged ≥80 years: A propensity score-matched multi-institutional study.

Preoperative FAN score predicts survival outcomes after radical cystectomy for bladder cancer.

Preoperative FAN score predicts survival outcomes after radical cystectomy for bladder cancer.

Myosteatosis Predicts Poor Prognosis in Patients With Castration-Resistant Prostate Cancer Treated With Enzalutamide.

Myosteatosis Predicts Poor Prognosis in Patients With Castration-Resistant Prostate Cancer Treated With Enzalutamide.

Bone scan index rise prior to osteonecrosis of the jaw with bone-modifying agents in prostate cancer.

Bone scan index rise prior to osteonecrosis of the jaw with bone-modifying agents in prostate cancer.

The First Case of Bacillus Calmette-Guérin-Induced Autoimmune Encephalitis.

The First Case of Bacillus Calmette-Guérin-Induced Autoimmune Encephalitis.

Real-world efficacy and safety of pembrolizumab plus lenvatinib in patients with metastatic renal cell carcinoma: a multi-institutional retrospective study.

Real-world efficacy and safety of pembrolizumab plus lenvatinib in patients with metastatic renal cell carcinoma: a multi-institutional retrospective study.

Pyonephrosis Caused by Ureteral Stricture Due to Syphilitic Granuloma: A Case Report

Pyonephrosis Caused by Ureteral Stricture Due to Syphilitic Granuloma: A Case Report

Perioperative safety and oncological outcomes of robot-assisted radical cystectomy in patients aged ≥80 years: A propensity score-matched multi-institutional study.

Perioperative safety and oncological outcomes of robot-assisted radical cystectomy in patients aged ≥80 years: A propensity score-matched multi-institutional study.